Sign in Create account

Roopa Industries Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 530991
₹45.90
▲ 0.90 (2.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
28/100
Weak
Valuation
39/100
Fairly Valued
Momentum
49/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹36 Cr
PE (TTM)
353.1
Industry median 36.1 (152 companies)
Price to Book
2.1
PEG (TTM)
-3.8
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-37.4
Free Cash Flow
₹4 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-20.27%
as of Sept. 30, 2025
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
20.98%
as of March 31, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
25.69%
as of March 31, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
3.28%
as of June 30, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
12.23%
as of Sept. 30, 2025
Industry median 14.05% (173 companies)
Current Ratio
1.25
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
1.76
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
1.05
as of March 31, 2026
Industry median 10.58 (182 companies)
Net Margin
2.29%
as of Dec. 31, 2025
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-3.73%
as of March 31, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
2.66%
as of March 31, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.65%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
15.75%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
10.85%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (1.76)
  • No Return on equity is 15% or more (10.8%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.0%
Low 44.0000 · High 45.9000
1W return
2.2%
Low 41.8400 · High 46.8500
1M return
-4.4%
Low 40.7100 · High 52.2000
52W return
-37.4%
Low 40.7100 · High 53.9000
Lifetime High ₹88.3500 (Sept. 20, 2022)
Lifetime Low ₹2.3700 (March 23, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
45.2
10D
45.1
20D
46.0
50D
49.2
100D
52.0
200D
54.7

Delivery and volume

Day avg. delivery
84.5%
Week avg. delivery
81.7%
Month avg. delivery
84.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

45.27
Pivot
First resistance46.53
Second resistance47.17
Third resistance48.43
First support44.63
Second support43.37
Third support42.73
Day RSI46.9
Day MFI37.5
Day MACD-1.43
Day MACD signal-1.85

Beta

1M1.38
3M1.05
1Y1.05
3Y0.38

Price change analysis

↓ -4.4%
Over 1 Month
LowHigh
40.7152.20
↓ -37.4%
Over 3 Months
LowHigh
40.7153.90
↓ -37.4%
Over 6 Months
LowHigh
40.7153.90
↓ -37.4%
Over 1 Year
LowHigh
40.7153.90
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 353.1 (own history: 24.0–563.8)
Fair Value Zone

Financials

View full financials, peers & valuation multiples →
Revenue (March 31, 2026)
₹30 Cr
Net profit (March 31, 2026)
₹— Cr
Basic EPS (March 31, 2026)
₹-1.8000

Ranks #159 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter48.03%
  • FII/FPI0.25%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 48.03% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.25% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 26 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
24 Sep 2024 NEO APEX SHARE BROKING SERVICES LLP Bulk Buy 65,000 83.0000 BSE
24 Sep 2024 NEO APEX SHARE BROKING SERVICES LLP Bulk Sell 65,000 83.0000 BSE
24 Sep 2024 SETU SECURITIES PVT. LTD. Bulk Sell 65,500 82.9400 BSE
24 Sep 2024 SETU SECURITIES PVT. LTD. Bulk Buy 65,500 66.3100 BSE
24 Sep 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 76,629 82.8600 BSE
24 Sep 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 76,629 66.6900 BSE
20 Jan 2010 STAR NIOCHEM PVT LTD Bulk Buy 54,094 9.1900 BSE
12 Jul 2007 VISHAL AGARWAL Bulk Sell 71,478 8.1400 BSE
11 Jul 2007 VISHAL AGARWAL Bulk Sell 51,385 7.4000 BSE
11 Jul 2007 M P VORA SHARES AND SECURITIES P LTD Bulk Sell 54,331 7.3200 BSE

All bulk and block deals →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Roopa Industries Ltd - 530991 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 AGM/EGM Roopa Industries Ltd - 530991 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
25 Sep 2026 Insider Trading / SAST Roopa Industries Ltd - 530991 - Closure of Trading Window
5 Sep 2026 AGM/EGM Roopa Industries Ltd - 530991 - Intimation Of Annual General Meeting For The FY 2025-26
5 Sep 2026 Others Roopa Industries Ltd - 530991 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Thin net profit margin (2.3%)
  • High financial leverage (Debt/Equity 1.76)

Opportunities

Data unavailable.

Threats

  • PE above 35 (353.1) -- priced for continued strong execution
  • Down 37.4% over the past year
  • Weak interest coverage (1.1x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Roopa Industries Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.